XML 58 R37.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value at Issuance Date and on Recurring Basis

The following tables present the fair value hierarchy for assets and liabilities that are measured at fair value at issuance date and on a recurring basis and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value (in thousands):

 

Fair Value Measurement as of December 31, 2023

 

 

Total
Carrying
Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

30,582

 

 

$

30,582

 

 

$

 

 

$

 

Total assets

 

$

30,582

 

 

$

30,582

 

 

$

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Legacy Allurion Common Stock Warrant Liabilities

 

$

821

 

 

$

 

 

$

 

 

$

821

 

Public Warrants

 

 

5,943

 

 

 

5,943

 

 

 

 

 

 

 

Revenue Interest Financing

 

 

36,200

 

 

 

 

 

 

 

 

 

36,200

 

PIPE Conversion Option

 

 

5,600

 

 

 

 

 

 

 

 

 

5,600

 

Earn-out Liability

 

 

23,990

 

 

 

 

 

 

 

 

 

23,990

 

Term Loan Derivative Liability

 

 

1,895

 

 

 

 

 

 

 

 

 

1,895

 

Success Fee Derivative Liability

 

 

14

 

 

 

 

 

 

 

 

 

14

 

Total Liabilities

 

$

74,463

 

 

$

5,943

 

 

$

 

 

$

68,520

 

 

Fair Value Measurement as of December 31, 2022

 

 

 

Total
Carrying
Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

4,925

 

 

$

4,925

 

 

$

 

 

$

 

Total assets

 

$

4,925

 

 

$

4,925

 

 

$

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Legacy Allurion Series C Common Stock Warrant Liability

 

$

340

 

 

$

 

 

$

 

 

$

340

 

Legacy Allurion Series B Preferred Stock Warrant Liability

 

 

303

 

 

 

 

 

 

 

 

 

303

 

Legacy Allurion Series A-1 Preferred Stock Warrant Liability

 

 

82

 

 

 

 

 

 

 

 

 

82

 

Other Common Stock Warrant Liabilities

 

 

255

 

 

 

 

 

 

 

 

 

255

 

Legacy Allurion Series C Preferred Stock Warrant Liability

 

 

684

 

 

 

 

 

 

 

 

 

684

 

Derivative Liability—Success Fee

 

 

180

 

 

 

 

 

 

 

 

 

180

 

Legacy Allurion Series D-1 Preferred Stock Warrant Liability

 

 

707

 

 

 

 

 

 

 

 

 

707

 

Total Liabilities

 

$

2,551

 

 

$

 

 

$

 

 

$

2,551

 

Schedule of Assumptions used in Pricing Model

The Company has classified the warrants within Level 3 of the hierarchy as the fair value is derived using the Black-Scholes option pricing model, which uses a combination of observable (Level 2) and unobservable (level 3) inputs. See table below for the assumptions used in the pricing model:

 

 

Measurement Date

 

Interest
Rate

 

Exercise
Price

 

Estimated Fair
Value of
Underlying
Share
Price

 

 

Expected
Volatility

 

Expected
Life (Years)

 

Legacy Allurion Series C Preferred Stock warrants (as converted to Common)

 

December 31, 2023

 

3.88%

 

6.73

 

 

3.74

 

 

100%

 

 

7.25

 

Other Common Stock

 

December 31, 2023

 

3.95%

 

1.05

 

 

3.74

 

 

100%

 

 

3.69

 

Legacy Allurion Series D-1 Preferred Stock warrants (as converted to Common)

 

December 31, 2023

 

3.88%

 

12.14

 

 

3.74

 

 

100%

 

7.25-8.71

 

 

 

Measurement Date

 

Interest
Rate

 

 

Exercise
Price

 

 

Estimated Fair
Value of
Underlying
Share
Price

 

 

Expected
Volatility

 

 

Expected
Life (Years)

 

Legacy Allurion Series A-1 Preferred Stock warrants (as converted to Rollover warrants)

 

December 31, 2022

 

 

4.42

%

 

$

1.90

 

 

$

6.75

 

 

 

69

%

 

 

0.25

 

Legacy Allurion Series B Preferred Stock warrants (as converted to Rollover warrants)

 

December 31, 2022

 

 

4.41

%

 

 

2.38

 

 

 

6.91

 

 

 

65

%

 

 

2.00

 

Legacy Allurion Series C Common Stock warrants (as converted to Rollover warrants)

 

December 31, 2022

 

 

4.11

%

 

 

0.01

 

 

 

4.54

 

 

 

63

%

 

 

4.00

 

Legacy Allurion Series C Preferred Stock warrants (as converted to Rollover warrants)

 

December 31, 2022

 

 

3.92

%

 

 

6.58

 

 

 

7.24

 

 

 

63

%

 

 

8.20

 

Other Common Stock Warrants

 

December 31, 2022

 

 

3.99

%

 

1.02 -1.10

 

 

 

4.54

 

 

 

63

%

 

4.6-4.7

 

Legacy Allurion Series D-1 Preferred Stock warrants (as converted to Rollover warrants)

 

December 31, 2022

 

3.88-3.92%

 

 

 

11.87

 

 

 

11.31

 

 

 

63

%

 

8.2-9.7

 

Schedule of Changes in Fair Values

The following table reconciles the changes in fair value for the years ended December 31, 2023 and 2022 of the warrant liabilities valued using Level 3 inputs:

 

 

Preferred Stock Warrants (as converted to Common)

 

 

Common Stock Warrants

 

 

Total

 

Balance – January 1, 2022

 

$

510

 

 

$

231

 

 

$

741

 

Fair value upon issuance

 

 

834

 

 

 

 

 

 

834

 

Change in fair value

 

 

456

 

 

 

365

 

 

 

821

 

Exercise of warrants

 

 

(23

)

 

 

 

 

 

(23

)

Balance – December 31, 2022

 

$

1,777

 

 

$

596

 

 

$

2,373

 

Change in fair value

 

 

(720

)

 

 

172

 

 

 

(548

)

Exercise of warrants

 

 

(75

)

 

 

 

 

 

(75

)

Derecognition of liability to equity

 

 

(340

)

 

 

(589

)

 

 

(929

)

Balance – December 31, 2023

 

$

642

 

 

$

179

 

 

$

821

 

Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method

The assumptions used in the Black-Scholes option-pricing model are as follows:

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Expected volatility

 

 

85.8

%

 

 

63

%

Risk-free interest rate

 

 

4.5

%

 

 

3.56

%

Expected dividend yield

 

 

%

 

 

%

Expected term (in years)

 

5.8

 

 

 

5.8

 

 

Public Warrants  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Changes in Fair Values

The changes in the fair values of the Success Fee derivative liability, 2023 Convertible Notes, PubCo Additional Shares liability, Base PubCo Shares and Backstop Shares liability, Revenue Interest Financing, PIPE Conversion Option, Earn-out liability, and Term Loan Derivative Liability categorized with Level 3 inputs for the years ended December 31, 2023 and 2022 were as follows:

 

 

Success Fee
Derivative Liability

 

 

2023
Convertible
Notes

 

 

PubCo
Share
Liability

 

 

Base
PubCo &
Backstop
Share
Liability

 

 

Revenue
Interest
Financing

 

 

PIPE
Conversion
Derivative

 

 

Earn-Out
Liability

 

 

Term Loan Derivative Liability

 

 

Total

 

Balance – January 1, 2022

 

$

159

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

159

 

Fair value upon issuance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value

 

 

19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

Exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance – December 31, 2022

 

$

178

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

178

 

Fair value upon issuance

 

 

 

 

$

28,700

 

 

 

3,370

 

 

 

3,264

 

 

 

40,000

 

 

 

3,340

 

 

 

53,040

 

 

 

1,895

 

 

 

133,609

 

Change in fair value

 

 

(164

)

 

 

3,751

 

 

 

(642

)

 

 

10,106

 

 

 

(3,408

)

 

 

2,260

 

 

 

(29,050

)

 

 

 

 

 

(17,147

)

Change in fair value - OCI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

700

 

 

 

 

 

 

 

 

 

 

 

 

700

 

Payments

 

 

 

 

 

(10,750

)

 

 

 

 

 

 

 

 

(1,092

)

 

 

 

 

 

 

 

 

 

 

 

(11,842

)

Derecognition of liability to
   equity

 

 

 

 

 

(21,701

)

 

 

(2,728

)

 

 

(13,370

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,799

)

Balance – December 31, 2023

 

$

14

 

 

$

 

 

$

 

 

$

 

 

$

36,200

 

 

$

5,600

 

 

$

23,990

 

 

$

1,895

 

 

$

67,699

 

Earn-Out Liability  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method The estimated fair value of the earn-out shares was determined using a Monte Carlo Simulation Method using the following assumptions at the valuation date:

 

 

December 31, 2023

Stock Price

 

3.74

Risk-free interest rate

 

3.9%

Expected term (in years)

 

4.6

Expected volatility

 

87.0%

Revenue Interest Financing and PIPE Conversion Option  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Schedule of Estimated Fair Value was Measured Using a Monte Carlo Simulation Method

The fair value of the PIPE Conversion Option was accounted for as a derivative under ASC 815. The instrument is measured using a Monte Carlo Simulation Method using the number of shares convertible of 1,065,341 and the following assumptions:

 

 

December 31, 2023

Stock Price

 

3.74

Risk-free interest rate

 

4.46%

Expected term (in years)

 

1.6

Expected volatility

 

82.5%